Novo Nordisk and Oxford University team up to further enhance diabetes research and help the new generation of research leaders.
The two have established an international fellowship program with the aim to support the development and career of young, exceptional research talent within diabetes. The new partnership will establish postdoctoral fellowship opportunities that will be hosted by Oxford University and funded by Novo Nordisk.
“We are honoured to establish the International PostDoctoral Fellowship Programme with Oxford University, which has such valuable expertise in the study and treatment of diabetes. By combining our company’s discovery and clinical development strengths with the research expertise and academic tradition of Oxford University, we can support the development of a new generation of exceptional diabetes researchers to eventually drive innovation further and improve the lives of the patients,” said Mads Krogsgaard Thomsen, executive vice president and chief science officer at Novo Nordisk in a press release.
A total of 12 young leading researchers are to be offered a 3-year grant to support their research within the fields of diabetes, metabolism and endocrinology. The goal with this new program states Novo Nordisk is to support the development of a new generation of research leaders while further developing scientific excellence within diabetes. The first fellows in the program will start next fall.
